$REGN
Regeneron Pharmaceuticals Inc
XNAS•Health Care•Pharmaceutical Preparations
$784.85
▼-0.58%-$4.60
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateRegeneron Pharmaceuticals Inc
XNAS•Health Care•Pharmaceutical Preparations
Why is REGN down today? It is at $784.85 (-0.58%), and our scanner flagged it 43 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment REGN spikes, and full due diligence on REGN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $REGN 43 times in the last 30 days. Create a free account to track $REGN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on REGN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for REGN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystREGENERON PHARMACEUTICALS, INC.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 3, 2026 · 16 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Mccourt Marion Officer | Sold (automatic/other) | -1K | sold 8.6% | 12K | $970K at $857.39 | Sep 3, 26 |
Guarini Kathryn Director | Sold (automatic/other) | -400 | sold 40% | 603 | $340K at $850.00 | Sep 2, 26 |
Guarini Kathryn Director | Other | 400 | added 66% | 1K | $288K at $719.37 | Sep 2, 26 |
Mccourt Marion Officer | Sold (automatic/other) | -1K | sold 8.5% | 13K | $1.0M at $850.00 | Sep 2, 26 |
Larosa Joseph J Officer | Sold (automatic/other) | -9K | sold 20% | 36K | $7.5M at $830.15 | Aug 19, 26 |
Larosa Joseph J Officer | Other | 12K 0.01% of company | added 37% | 45K | $4.7M at $381.92 | Aug 19, 26 |
Fenimore Christopher R. Officer | Sold (automatic/other) | -5K | sold 19% | 20K | $3.7M at $813.47 | Aug 18, 26 |
Fenimore Christopher R. Officer | Other | 6K | added 34% | 25K | $2.4M at $381.92 | Aug 18, 26 |
Zoghbi Huda Y Director | Sold (automatic/other) | -800 | sold 32% | 2K | $640K at $800.00 | Aug 10, 26 |
Zoghbi Huda Y Director | Other | 800 | added 47% | 3K | $301K at $376.69 | Aug 10, 26 |
Guarini Kathryn Director | Sold (automatic/other) | -400 | sold 40% | 603 | $320K at $800.00 | Aug 10, 26 |
Guarini Kathryn Director | Other | 400 | added 66% | 1K | $288K at $719.37 | Aug 10, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Curated groups REGN belongs to. Tap one to see every member with today's move and why the group is moving.
Here is the latest on REGN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for REGN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
REGN last traded at $784.85, down 0.58% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Regeneron Pharmaceuticals Inc (REGN) is next expected to report earnings on Tuesday, October 27, 2026, about 37 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. REGN currently has a dividend yield of about 0.48% ($3.76 per share per year). Dividend figures can change; this is not investment advice.
The REGN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged REGN 43 times in the last 30 days.
REGN (Regeneron Pharmaceuticals Inc) trades on XNAS, with a market cap of about $80.80B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge REGN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$REGN discussion
Sign in to ask a question or join the discussion.